How phosphorylation regulates the activity of p53

Journal of Molecular Biology

Volumn 263, Issue 2, 1996, Pages 103-113

  Steegenga, Wilma T ^a,b   Van Der Eb, Alex J ^a   Jochemsen, A G ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b Lab for Physiological Chemistry   (Netherlands)

Author keywords

Conformation; DNA binding; P53; Phosphorylation; Transcription

Indexed keywords

MITOGENIC AGENT; PHOSPHOTRANSFERASE; PROTEIN BAX; PROTEIN P21; PROTEIN P53;

AMINO TERMINAL SEQUENCE; APOPTOSIS; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL CYCLE; CONSENSUS SEQUENCE; DNA DAMAGE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; REVIEW; STRESS; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 0030601784     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1996.0560     Document Type: Review

References (98)

1. Addison, C., Jenkins, J. R. & Sturzbecher, H. W. (1990). The p53 nuclear localisation signal is structurally linked to a p34cdc2 kinase motif. Oncogene, 5, 423-426.
2. Aloni-Grinstein, R., Zan-Bar, I., Alboum, I., Goldfinger, N. & Rotter, V. (1993). Wild-type p53 functions as a control protein in the differentiation pathway of the B-cell lineage. Oncogene, 8, 3297-3305.
3. Aloni-Grinstein, R., Schwartz, D. & Rotter, V. (1995). Accumulation of wild-type p53 protein upon gamma-irradiation induces a G2 arrest-dependent immunoglobulin kappa light chain gene expression. EMBO J. 14, 1392-1401.
4. Bakalkin, G., Yakovleva, T., Selivanova, G., Magnusson, K. P., Szekely, L., Kiseleva, E., Klein, G., Terenius, L. & Wiman, K. G. (1994). p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. Proc. Natl Acad. Sci. USA, 91, 413-417.
5. Bakalkin, G., Selivanova, G., Yakovleva, T., Kiseleva, E., Kashuba, E., Magnusson, K. P., Szekely, L., Klein, G., Terenius, L. & Wiman, K. G. (1995). p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain. Nucl. Acids Res. 23, 362-369.
6. Bargonetti, J., Manfredi, J. J., Chen, X., Marshak, D. R. & Prives, C. (1993). A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein. Genes Dev. 7, 2565-2574.
7. Baudier, J., Delphin, C., Grunwald, D., Khochbin, S. & Lawrence, J. J. (1992). Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein. Proc. Natl Acad. Sci. USA, 89, 11627-11631.
8. Bischoff, J. R., Friedman, P. N., Marshak, D. R., Prives, C. & Beach, D. (1990). Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. Proc. Natl Acad. Sci. USA, 87, 4766-4770.
9. Bischoff, J. R., Casso, D. & Beach, D. (1992). Human p53 inhibits growth in Schizosaccharomyces pombe. Mol. Cell. Biol. 12, 1405-1411.
10. Brain, R. & Jenkins, J. R. (1994). Human p53 directs DNA strand reassociation and is photolabelled by 8-azido ATP. Oncogene, 9, 1775-1780.
11. Chowdary, D. R., Dermody, J. J., Jha, K. K. & Ozer, H. L. (1994). Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway. Mol. Cell. Biol. 14, 1997-2003.
12. Ciechanover, A., DiGiuseppe, J. A., Bercovich, B., Orian, A., Richter, J. D., Schwartz, A. L. & Brodeur, G. M. (1991). Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Proc. Natl Acad. Sci. USA, 88, 139-143.
13. Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L. & Wyllie, A. H. (1993). Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature, 362, 849-852.
14. Cross, S. M., Sanchez, C. A., Morgan, C. A., Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H. & Reid, B. J. (1995). A p53-dependent mouse spindle checkpoint. Science, 267, 1353-1356.
15. Delphin, C. & Baudier, J. (1994). The protein kinase C activator, phorbol ester, cooperates with the wild-type p53 species of Ras-transformed embryo fibroblasts growth arrest. J Biol. Chem. 269, 29579-29587.
16. Dippold, W. G., Jay, G., DeLeo, A. B., Khoury, G. & Old, L. J. (1981). p53 transformation-related protein: detection by monoclonal antibody in mouse and human cells. Proc. Natl Acad. Sci. USA, 78, 1695-1699.
17. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Jr, Butel, J. S. & Bradley, A. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 356, 215-221.
18. Dutta, A., Ruppert, J. M., Aster, J. C. & Winchester, E. (1993). Inhibition of DNA replication factor RPA by p53. Nature, 365, 79-82.
19. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinder, K. W. & Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825.
20. Feinstein, E., Gale, R. P., Reed, J. & Canaani, E. (1992). Expression of the normal p53 gene induces differentiation of K562 cells. Oncogene, 7, 1853-1857.
21. Fields, S. & Jang, S. K. (1990). Presence of a potent transcription activating sequence in the p53 protein. Science, 249, 1046-1049.
22. Filhol, O., Baudier, J., Delphin, C., Loue-Mackenbach, P., Chambaz, E. M. & Cochet, C. (1992). Casein kinase II and the tumor suppressor protein P53 associate in a molecular complex that is negatively regulated upon P53 phosphorylation. J. Biol. Chem. 267, 20577-20583.
23. Fiscella, M., Ullrich, S. J., Zambrano, N., Shields, M. T., Lin, D., Lees-Miller, S. P., Anderson, C. W., Mercer, W. E. & Appella, E. (1993). Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression. Oncogene, 8, 1519-1528.
24. Fiscella, M., Zambrano, N., Ullrich, S. J., Unger, T., Lin, D., Cho, B., Mercer, W. E., Anderson, C. W. & Appella, E. (1994). The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities. Oncogene, 9, 3249-3257.
25. Fontoura, B. M., Sorokina, E. A., David, E. & Carroll, R. B. (1992). p53 is covalently linked to 5.85 rRNA. Mol. Cell. Biol. 12, 5145-5151.
26. Fuchs, B., O'Connor, D., Fallis, L., Scheidtmann, K. H. & Lu, X. (1995). p53 phosphorylation mutants retain transcription activity. Oncogene, 10, 789-793.
27. Funk, W. D., Pak, D. T., Karas, R. H., Wright, W. E. & Shay, J. W. (1992). A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell. Biol. 12, 2866-2871.
28. Herrmann, C. P., Kraiss, S. & Montenarh, M. (1991). Association of casein kinase II with immunopurified p53. Oncogene, 6, 877-884.
29. Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C. C. (1991). p53 mutations in human cancers. Science, 253, 49-53.
30. Hupp, T. R. & Lane, D. P. (1994). Regulation of the cryptic sequence-specific DNA-binding function of p53 by protein kinases. Cold Spring Harbor Symp. Quant. Biol. 59, 195-206.
31. Hupp, T. R., Meek, D. W., Midgley, C. A. & Lane, D. P. (1992). Regulation of the specific DNA binding function of p53. Cell, 71, 875-886.
32. Jamal, S. & Ziff, E. B. (1995). Raf phosphorylates p53 in vitro and potentiates p53-dependent transcriptional transactivation in vivo. Oncogene, 10, 2095-2101.
33. Kastan, M. B., Zhan, Q., el-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B. & Fornace, A. J., Jr (1992). A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71, 587-597.
34. Kern, S. E., Pietenpol, J. A., Thiagalingam, S., Seymour, A., Kinder, K. W. & Vogelstein, B. (1992). Oncogenic forms of p53 inhibit p53-regulated gene expression. Science, 256, 827-830.
35. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V. & Kastan, M. B. (1992). Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl Acad. Sci. USA, 89, 7491-7495.
36. Lane, D. P. & Crawford, L. V. (1979). T antigen is bound to a host protein in SV40-transformed cells. Nature, 278, 261-263.
37. Lee, S., Elenbaas, B., Levine, A. & Griffith, J. (1995). p53 and its C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell, 81, 1031-1020.
38. Lees-Miller, S. P., Sakaguchi, K., Ullrich, S. J., Appella, E. & Anderson, C. W. (1992). Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol. Cell. Biol. 12, 5041-5049.
39. Lin, W. C. & Desiderio, S. (1993). Regulation of V(D)J recombination activator protein RAG-2 by phosphorylation. Science, 260, 953-959.
40. Linzer, D. I. & Levine, A. J. (1979). Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell, 17, 43-52.
41. Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T. & Tlsty, T. D. (1992). Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70, 923-935.
42. Lu, H. & Levine, A. J. (1995). Human TAFII31 protein is a transcriptional coactivator of the p53 protein. Proc. Natl Acad. Sci. USA, 9295, 5154-5158.
43. Mack, D. H., Vartikar, J., Pipas, J. M. & Laimins, L. A. (1993). Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53. Nature, 363, 281-283.
44. Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Jr., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z. & Tainsky, M. A. (1990). Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science, 250, 1233-1238.
45. Martin, D. W., Munoz, R. M., Subler, M. A. & Deb, S. (1993). p53 binds to the TATA-binding protein-TATA complex. J. Biol. Chem. 268, 13062-13067.
46. Martinez, J., Georgoff, I. & Levine, A. J. (1991). Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev. 5, 151-159.
47. Maxwell, S. A. & Roth, J. A. (1994). Posttranslational regulation of p53 tumor suppressor protein function. Crit. Rev. Oncog. 5, 23-57.
48. Mayr, G. A., Reed, M., Wang, P., Wang, Y., Schweds, J. F. & Tegtmeyer, P. (1995). Serine phosphorylation in the NH2 terminus of p53 facilitates transactivation. Cancer Res. 55, 2410-2417.
49. McClure, J. E., McClure, J. A. & Shearer, W. T. (1992). Phosphorylation-associated conformation shift of anti-oncogene phosphoprotein p53 in concanavalin-A activated human T lymphocytes. Biochem. Biophys. Res. Commun. 189, 1701-1708.
50. Meek, D. W. & Eckhart, W. (1988). Phosphorylation of p53 in normal and simian virus 40-transformed NIH 3T3 cells. Mol. Cell. Biol. 8, 461-465.
51. Milne, D. M., Palmer, R. H., Campbell, D. G. & Meek, D. W. (1992a). Phosphorylation of the p53 tumour-suppressor protein at three N-terminal sites by a novel casein kinase I-like enzyme. Oncogene, 7, 1361-1369.
52. Milne, D. M., Palmer, R. H. & Meek, D. W. (1992b). Mutation of the casein kinase II phosphorylation site abolishes the anti-proliferative activity of p53. Nucl. Acids. Res. 20, 5565-5570.
53. Milne, D. M., Campbell, D. G., Caudwell, F. B. & Meek, D. W. (1994). Phosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases. J. Biol. Chem. 269, 9253-9260.
54. Milne, D. M., Campbell, L. E., Campbell, D. G. & Meek, D. W. (1995). p53 is phosphorylated in vitro and in vivo by an ultraviolet radiation-induced protein kinase characteristic of the c-Jun kinase, JNK1. J. Biol. Chem. 270, 5511-5518.
55. Milner, J. (1994). Forms and functions of p53. [Review]. Semin. Cancer Biol. 5, 211-219.
56. Milner, J., Cook, A. & Mason, J. (1990). p53 is associated with p34cdc2 in transformed cells. EMBO J. 9, 2885-2889.
57. Miyashita, T., Harigai, M., Hanada, M. & Reed, J. C. (1994). Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res. 54, 3131-3135.
58. Miyashita, T. & Reed, J. C. (1995). Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-299.
59. Muller, E. & Scheidtmann, K. H. (1995). Purification and characterization of a protein kinase which is activated by SV40 large T-antigen and phosphorylates the tumor suppressor protein p53. Oncogene, 10, 1175-1185.
60. Nigro, J. M., Sikorski, R., Reed, S. I. & Vogelstein, B. (1992). Human p53 and CDC2Hs genes combine to inhibit the proliferation of Saccharomyces cerevisiae. Mol. Cell. Biol. 12, 1357-1365.
61. Oberosler, P., Hloch, P., Ramsperger, U. & Stahl, H. (1993). p53-catalyzed annealing of complementary single-stranded nucleic acids. EMBO J. 12, 2389-2396.
62. Patschinsky, T., Knippschild, U. & Deppert, W. (1992). Species-specific phosphorylation of mouse and rat p53 in simian virus 40-transformed cells. J. Virol. 66, 3846-3859.
63. Pavletich, N. P., Chambers, K. A. & Pabo, C. O. (1993). The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. Genes Dev. 7, 2556-2564.
64. Picksley, S. M., Meek, D. W. & Lane, D. P. (1992). The conformational change of a murine temperature-sensitive p53 protein is independent of a change in phosphorylation status. Oncogene, 7, 1649-1651.
65. Ragimov, N., Krauskopf, A., Navot, N., Rotter, V., Oren, M. & Aloni, Y. (1993). Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif. Oncogene, 8, 1183-1193.
66. Raycroft, L., Wu, H. Y. & Lozano, G. (1990). Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science, 249, 1049-1051.
67. Rolley, N. & Milner, J. (1994). Specific DNA binding by p53 is independent of mutation at serine 389, the casein kinase II site. Oncogene, 9, 3067-3070.
68. Samad, A., Anderson, C. W. & Carroll, R. B. (1986). Mapping of phosphomonoester and apparent phosphodiester bonds of the oncogene product p53 from simian virus 40-transformed 3T3 cells. Proc. Natl Acad. Sci. USA, 83, 897-901.
69. Sarnow, P., Ho, Y. S., Williams, J. & Levine, A. J. (1982). Adenovirus Elb-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell, 28, 387-394.
70. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J. &Howley, P. M. (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63, 1129-1136.
71. Scheidtmann, K. H. & Haber, A. (1990). Simian virus 40 large T antigen induces or activates a protein kinase which phosphorylates the transformation-associated protein p53. J. Virol. 64, 672-679.
72. Scheidtmann, K. H., Mumby, M. C., Rundell, K. & Walter, G. (1991a). Dephosphorylation of simian virus 40 large-T antigen and p53 protein by protein phosphatase 2A: inhibition by small-t antigen. Mol. Cell. Biol. 11, 1996-2003.
73. Scheidtmann, K. H., Virshup, D. M. & Kelly, T. J. (1991b). Protein phosphatase 2A dephosphorylates simian virus 40 large T antigen specifically at residues involved in regulation of DNA-binding activity. J. Virol. 65, 2098-2101.
74. Schwartz, D., Goldfinger, N. & Rotter, V. (1993). Expression of p53 protein in spermatogenesis is confined to the tetraploid pachytene primary spermatocytes. Oncogene, 8, 1487-1494.
75. Selvakumaran, M., Lin, H. K., Miyashita, T., Wang, H. G., Krajewski, S., Reed, J. C., Hoffman, B. & Liebermann, D. (1994). Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene, 9, 1791-1798.
76. Seto, E., Usheva, A., Zambetti, G. P., Momand, J., Horikoshi, N., Weinmann, R., Levine, A. J. & Shenk, T. (1992). Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc. Natl Acad. Sci. USA, 89, 12028-12032.
77. Shaulsky, G., Ben-Ze'ev, A. & Rotter, V. (1990). Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells. Oncogene, 5, 1707-1711.
78. Skouv, J., Jensen, P. O., Forchhammer, J., Larsen, J. K. & Lund, L. R. (1994). Tumor-promoting phorbol ester transiently down-modulates the p53 level and blocks the cell cycle. Cell Growth Differ. 5, 329-340.
79. Spandau, D. F. (1994). Distinct conformations of p53 are observed at different stages of keratinocyte differentiation. Oncogene, 9, 1861-1868.
80. Srivastava, S., Zou, Z. Q., Pirollo, K., Blattner, W. & Chang, E. H. (1990). Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature, 348, 747-749.
81. Steegenga, W. T., Shvarts, A., van Laar, T., van der Eb, A. J. & Jochemsen, A. G. (1995). Altered phosphorylation and oligomerization of p53 in adenovirus type 12-transformed cells. Oncogene, 11, 49-57.
82. Steegenga, W. T., van Laar, T., Riteco, N., Mandarine, A., Shvarts, A., van der Eb, A. J. & Jochemsen, A. G. (1996). Adenovirus E1A proteins inhibit transcription activation by p53. Mol. Cell. Biol. 16, 2101-2109.
83. Stürzbecher, H. W., Montenarh, M. & Henning, R. (1987). Enhanced protein phosphorylation in SV40-transformed and -infected cells. Virology, 160, 445-455.
84. Stürzbecher, H. W., Maimets, T., Chumakov, P., Brain, R., Addison, C., Simanis, V., Rudge, K., Philp, R., Grimaldi, M., Court, W. et al. (1990). p53 interacts with p34cdc2 in mammalian cells: implications for cell cycle control and oncogenesis. Oncogene, 5, 795-781.
85. Tack, L. C. & Wright, J. H. (1992). Altered phosphorylation of free and bound forms of monkey p53 and simian virus 40 large T antigen during lytic infection. J. Virol. 66, 1312-1320.
86. Takahashi, K. & Suzuki, K. (1993). Association of insulin-like growth-factor-I-induced DNA synthesis with phosphorylation and nuclear exclusion of p53 in human breast cancer MCF-7 cells. Int. J. Cancer, 55, 453-458.
87. Takenaka, I., Morin, F., Seizinger, B. R. & Kley, N. (1995). Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases. J. Biol. Chem. 270, 5405-5411.
88. Thut, C. J., Chen, J. L., Klemm, R. & Tjian, R. (1995). p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. Science, 267, 100-104.
89. Ullrich, S. J., Anderson, C. W., Mercer, W. E. & Appella, E. (1992). The p53 tumor suppressor protein, a modulator of cell proliferation. J. Biol. Chem. 267, 15259-15262.
90. Ullrich, S. J., Sakaguchi, K., Lees-Miller, S. P., Fiscella, M., Mercer, W. E., Anderson, C. W. & Appella, E. (1993). Phosphorylation at Ser-15 and Ser-392 in mutant p53 molecules from human tumors is altered compared to wild-type p53. Proc. Natl Acad. Sci. USA, 90, 5954-5958.
91. Unger, T., Mietz, J. A., Scheffner, M., Yee, C. L. & Howley, P. M. (1993). Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression. Mol. Cell. Biol. 13, 5186-5194.
92. Wang, X. W., Yeh, H., Schaeffer, L., Roy, R., Moncollin, V., Egly, J. M., Wang, Z., Freidberg, E. C., Evans, M. K. & Taffe, B. G. (1995). p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat. Genet. 10, 188-195.
93. Wang, Y. & Prives, C. (1995). Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature, 376, 88-91.
94. Wang, Y., Reed, M., Wang, P., Stenger, J. E., Mayr, G., Anderson, M. E., Schwedes, J. F. & Tegtmeyer, P. (1993). p53 domains: identification and characterization of two autonomous DNA-binding regions. Genes Dev. 7, 2575-2586.
95. Xiao, H., Pearson, A., Coulombe, B., Truant, R., Zhang, S., Regier, J. L., Triezenberg, S. J., Reinberg, D., Flores, O. & Ingles, C. J. (1994). Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol. Cell. Biol. 14, 7013-7024.
96. Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C. & Wahl, G. M. (1992). Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell, 70, 937-948.
97. Yonish-Rouach, E., Grunwald, D., Wilder, S., Kimchi, A., May, E., Lawrence, J. J., May, P. & Oren, M. (1993). p53-mediated cell death: relationship to cell cycle control. Mol. Cell. Biol. 13, 1415-1423.
98. Zantema, A., Schrier, P. I., Davis-Olivier, A., van Laar, T., Vaessen, R. T. & van der Eb, A. J. (1985). Adenovirus serotype determines association and localization of the large E1B tumor antigen with cellular tumor antigen p53 in transformed cells. Mol. Cell. Biol. 5, 3084-3091.